20 studies found for:    Open Studies | "Leishmaniasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leishmaniasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
2 Available Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
3 Recruiting The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
Condition: Leishmaniasis
Interventions: Drug: Miltefosine and Pentoxifylline;   Drug: Meglumine antimoniate
4 Not yet recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
5 Not yet recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
6 Recruiting Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Paromomycin
7 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
8 Recruiting Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
9 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
10 Unknown  Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
11 Unknown  Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Topical Amphotericin B at 3%
12 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
Condition: Leishmaniasis or Other Uses of Miltefosine
Intervention: Drug: Miltefosine
13 Not yet recruiting Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Condition: Leishmaniasis
Interventions: Drug: Topical Amphotericin-B 0.4% liposomal gel;   Drug: Placebo
14 Unknown  Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
15 Not yet recruiting Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Pentostam
16 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
17 Recruiting Pharmacokinetics of Miltefosine in Children and Adults
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
18 Recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
19 Unknown  Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
Condition: Cutaneous Leihmaniasis
Intervention: Drug: Miltefosine , meglumine antimoniate
20 Recruiting Diagnosis and Treatment of Leishmanial Infections
Condition: Leishmaniasis
Intervention:

Indicates status has not been verified in more than two years